Anti-Diarrheal Drugs Market size is estimated to reach $290m by 2025 and is poised to grow at a CAGR of 2.7% during the forecast period 2020-2025. Antidiarrheal drugs are used to treat abrupt diarrhea and possess the mechanism of slowing down the movement of the gut and helps to diminish the number of bowel movements and make the stools less watery. Distinct causes of diarrhea can be a virus such as a rotavirus, hepatitis, a bacterium such as E.coli, Shigella, and parasites causing amoebiasis and giardiasis. Majority of the events of diarrhea are recognized to be concluded with simple dietary modifications and not require treatment, however, in certain cases of severe diarrhea, laboratory assessment is requisite which includes blood tests, and stool specimen evaluation to analyze the type of diarrhea. The increasing incidence of the diarrheal disease is creating a demand for Antidiarrheal Drugs, thereby, leading to market growth.
By Type- Segment Analysis
The global Anti-Diarrheal Drugs market based on the type has OTC Drugs, Prescription Drugs, and others. OTC Drugs registered high revenue in the year 2019 and is poised to grow for the forecast period (2020-2025). The growth is owing to the growing demand for personalized medicine for treating minor ailments and introduction of treatment protocols by healthcare payers.
Request for Sample of the Report @ https://www.industryarc.com/pdfdownload.php?id=17439
Report Price: $ 4500 (Single User License)
By Application – Segment Analysis
The global Anti-Diarrheal Drugs market based on end-use, can be further segmented into adults, children, and others. Children segment was on top in terms of revenue in the year 2019 and is poised to grow during the forecast period (2020-2025). According to the WHO, diarrhea is the second leading cause of death, especially in children less than 5 years of age. Moreover, diarrhea is known to be a major cause of malnutrition in children, since the disease deprives the child of the nutrition required for their proper growth.
By Geography – Segment Analysis
North America had the major share of market in the year 2019. This is owing to high prevalence of diarrhea and higher adoption rate for antidiarrheal drugs. Furthermore, Asia-Pacific is estimated to experience rapid growth during the forecast period 2020-2025, wherein emerging economies such as China and India are the key consumers of antidiarrheal drugs owing to unhygienic and improper sanitation procedures, increasing awareness and infrastructure.
Drivers – Anti-Diarrheal Drugs Market
Rise in Diarrheal disease
The Anti-Diarrheal Drugs market is poised to grow owing to increasing incidence of the diarrheal disease. The various factors that are driving the global antidiarrheal drugs market are rising government initiatives for improvement in healthcare facilities, growing awareness for antidiarrheal drugs, and increasing prevalence for diarrhea cases.
Talk to one of our sales representative about the full report by providing your details in the link below:
Challenges – Anti-Diarrheal Drugs Market
Side effects of Anti-Diarrheal drugs
Various side effects associated with the uptake of antidiarrheal drugs, such as constipation, fullness and bloating are restraining the global antidiarrheal drugs market. In addition, traditional and home remedies are still popular in emerging countries. This controlled the market for Anti-Diarrheal Drugs.
Anti-Diarrheal Drugs Market Industry outlook
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Anti-Diarrheal Drugs Market. Key companies of this market GlaxoSmithKline, Proctor & Gamble, Pfizer, Actelion, Perrigo, Lupin, Glenmark Pharmaceuticals, Sanofi Aventis, Merck & Co., Novartis.
In February 2020, Glenmark Pharmaceuticals and Hikma enter into an Exclusive Licensing Agreement for commercializing Ryaltris Seasonal Allergic Rhinitis Spray in the US.
In December 2019, Sanofi Aventis and Regeneron Pharmaceuticals, Inc today announced their intent to simplify their antibody collaboration for Kevzara and Praluent by restructuring into a royalty-based agreement.
Geographically, the North America area is poised to see extraordinary development owing to high prevalence of diarrhea and higher adoption rate for antidiarrheal drugs and is set to continue during the forecast period (2020-2025).
The increasing incidence of the diarrheal disease is creating a demand for Anti diarrheal Drugs, thereby, leading to market growth during the forecast period 2020-2025.
Various side effects associated with the uptake of antidiarrheal drugs, such as constipation, fullness and bloating are restraining the global antidiarrheal drugs market.
Detailed analysis on the Strength, Weakness and Opportunities of the prominent players operating in the market will be provided in the Anti-Diarrheal Drugs Market report.
Related Reports :
A. Antiemetic Drugs Market Analysis
B. Antiepileptic Drugs Market
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to email@example.com to discuss more about our consulting services.